MarketCap
Facebook
X
TelegramQuarterly report 2022-Q4
added 02-09-2023
Meridian Bioscience ROE Ratio 2011-2026 | VIVO
Annual ROE Ratio Meridian Bioscience
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11.54 | 21.75 | 18.65 | 12.77 | 13.6 | 12.71 | 19.36 | 21.43 | 21.58 | 24.53 | 23.38 | 19.37 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 24.53 | 11.54 | 18.39 |
Quarterly ROE Ratio Meridian Bioscience
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.59 | 19.79 | 15.74 | 19.36 | 19.31 | 20.84 | 23.47 | 29.71 | 31.69 | 23.52 | 23.05 | 15.76 | 7.59 | 10.69 | 11.64 | 12.89 | 15.99 | 15.1 | 15.38 | 11.7 | 10.81 | 10.95 | 10.87 | 15.99 | 16.12 | 17.6 | 19.41 | 19.64 | 21.23 | 20.87 | 20.84 | 20.84 | 20.39 | 20.19 | 21.01 | 22.08 | 23.78 | 25.19 | 25.3 | 24.76 | 24.09 | 22.74 | 21.58 | 20.49 | 19.3 | 4.84 | 4.93 | 4.75 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 31.69 | 4.75 | 17.93 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
22.45 | $ 120.96 | -0.75 % | $ 36.8 B |  USA |
 |
Burning Rock Biotech Limited
BNR
|
-43.17 | $ 21.56 | 4.31 % | $ 232 M |  China |
 |
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M | USA |
 |
Aspira Women's Health
AWH
|
184.36 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1734.41 | - | - | $ 9.42 M |  Israel |
 |
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | USA |
 |
Danaher Corporation
DHR
|
6.88 | $ 195.5 | 0.39 % | $ 139 B | USA |
 |
CareDx, Inc
CDNA
|
-7.05 | $ 21.29 | -0.61 % | $ 1.13 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M |  Britain |
 |
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | USA |
 |
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | USA |
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
-227.33 | $ 1.67 | 7.05 % | $ 2.22 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.66 | - | - | $ 19.8 B | USA |
 |
Castle Biosciences
CSTL
|
4.0 | $ 25.16 | 0.44 % | $ 699 M | USA |
 |
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B |  Australia |
 |
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | USA |
 |
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
-4.56 | $ 185.54 | 0.9 % | $ 9.2 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | USA |
 |
Interpace Biosciences
IDXG
|
109.89 | $ 2.05 | -4.17 % | $ 9.07 M | USA |
 |
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
9.97 | $ 29.19 | -1.72 % | $ 20 B |  Niderland |
 |
Illumina
ILMN
|
-51.54 | $ 132.86 | -1.22 % | $ 21.1 B | USA |
 |
Fulgent Genetics
FLGT
|
-3.77 | $ 16.18 | -0.49 % | $ 489 M | USA |
 |
Medpace Holdings
MEDP
|
98.27 | $ 528.44 | 1.51 % | $ 15.2 B | USA |
 |
Guardant Health
GH
|
419.18 | $ 91.07 | 0.79 % | $ 11.4 B | USA |
 |
QIAGEN N.V.
QGEN
|
11.25 | - | - | $ 10.6 B | Niderland |
 |
Biomerica
BMRA
|
-121.14 | $ 2.18 | - | $ 5.01 M | USA |
 |
Senseonics Holdings
SENS
|
-113.21 | $ 6.87 | 1.48 % | $ 287 M | USA |
 |
ICON Public Limited Company
ICLR
|
8.31 | $ 117.12 | -2.14 % | $ 9.66 B |  Irlanda |
 |
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | Israel |
 |
Laboratory Corporation of America Holdings
LH
|
10.17 | $ 269.19 | -0.55 % | $ 22.4 B | USA |
 |
Celcuity
CELC
|
-176.06 | $ 120.09 | -1.94 % | $ 5.62 B | USA |
 |
Lantheus Holdings
LNTH
|
21.43 | $ 83.97 | 0.18 % | $ 5.67 B | USA |
 |
ENDRA Life Sciences
NDRA
|
-310.93 | $ 6.01 | -6.03 % | $ 4.73 M | USA |
 |
NeoGenomics
NEO
|
-12.91 | $ 8.23 | -1.44 % | $ 1.05 B | USA |
 |
Myriad Genetics
MYGN
|
-99.43 | $ 5.14 | 1.18 % | $ 476 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
13.84 | $ 196.31 | 0.66 % | $ 21.8 B | USA |
 |
Natera
NTRA
|
-77.62 | $ 207.74 | -0.32 % | $ 20.4 B | USA |
 |
Neogen Corporation
NEOG
|
-52.72 | $ 9.63 | 1.26 % | $ 2.09 B | USA |
 |
Invitae Corporation
NVTA
|
-98.02 | - | - | $ 21.2 M | USA |
 |
National Research Corporation
NRC
|
82.92 | $ 18.18 | 0.83 % | $ 407 M | USA |
 |
Organovo Holdings
ONVO
|
-23.71 | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
162.49 | - | -16.95 % | $ 1.54 M | USA |
 |
Pacific Biosciences of California
PACB
|
-10214.54 | $ 1.74 | 2.96 % | $ 522 M | USA |